ExplorPubmed, Main, Corpus, bibRecord, 000326

Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010.

Identifieur interne : 000326 ( Main/Corpus ); précédent : 000325; suivant : 000327

Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010.

Auteurs : O. Wichmann ; P. Stocker ; G. Poggensee ; D. Altmann ; D. Walter ; W. Hellenbrand ; G. Krause ; T. Eckmanns

Source :

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [ 1560-7917 ] ; 2010.

RBID : pubmed:20460094

English descriptors

KwdEn :
- Adolescent, Adult, Disease Outbreaks, Germany (epidemiology), Humans, Influenza A Virus, H1N1 Subtype (isolation & purification), Influenza Vaccines, Influenza, Human (epidemiology), Influenza, Human (prevention & control), Interviews as Topic, Middle Aged, Treatment Outcome, Young Adult.
MESH :
- chemical : Influenza Vaccines.
- geographic , epidemiology : Germany.
- epidemiology : Influenza, Human.
- isolation & purification : Influenza A Virus, H1N1 Subtype.
- prevention & control : Influenza, Human.
- Adolescent, Adult, Disease Outbreaks, Humans, Interviews as Topic, Middle Aged, Treatment Outcome, Young Adult.

Abstract

During the 2009 influenza pandemic, a monovalent AS03-adjuvanted vaccine was almost exclusively used in Germany for immunisation against the 2009 pandemic influenza A(H1N1) virus. One-dose vaccination was recommended for all age groups. We applied the screening method for the rapid assessment of vaccine effectiveness (VE) based on reported data of vaccinated and unvaccinated pandemic influenza cases and vaccination coverage estimates. Preliminary results demonstrate excellent VE in persons aged 14-59 years (96.8%; 95% confidence interval (CI): 95.2-97.9) and moderately high VE in those 60 years or older (83.3%; 95% CI: 71.0-90.5).

PubMed: 20460094

Links to Exploration step

pubmed:20460094

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010.</title>
<author><name sortKey="Wichmann, O" sort="Wichmann, O" uniqKey="Wichmann O" first="O" last="Wichmann">O. Wichmann</name>
<affiliation><nlm:affiliation>Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany. WichmannO@rki.de</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Stocker, P" sort="Stocker, P" uniqKey="Stocker P" first="P" last="Stocker">P. Stocker</name>
</author>
<author><name sortKey="Poggensee, G" sort="Poggensee, G" uniqKey="Poggensee G" first="G" last="Poggensee">G. Poggensee</name>
</author>
<author><name sortKey="Altmann, D" sort="Altmann, D" uniqKey="Altmann D" first="D" last="Altmann">D. Altmann</name>
</author>
<author><name sortKey="Walter, D" sort="Walter, D" uniqKey="Walter D" first="D" last="Walter">D. Walter</name>
</author>
<author><name sortKey="Hellenbrand, W" sort="Hellenbrand, W" uniqKey="Hellenbrand W" first="W" last="Hellenbrand">W. Hellenbrand</name>
</author>
<author><name sortKey="Krause, G" sort="Krause, G" uniqKey="Krause G" first="G" last="Krause">G. Krause</name>
</author>
<author><name sortKey="Eckmanns, T" sort="Eckmanns, T" uniqKey="Eckmanns T" first="T" last="Eckmanns">T. Eckmanns</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="RBID">pubmed:20460094</idno>
<idno type="pmid">20460094</idno>
<idno type="wicri:Area/Main/Corpus">000326</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000326</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010.</title>
<author><name sortKey="Wichmann, O" sort="Wichmann, O" uniqKey="Wichmann O" first="O" last="Wichmann">O. Wichmann</name>
<affiliation><nlm:affiliation>Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany. WichmannO@rki.de</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Stocker, P" sort="Stocker, P" uniqKey="Stocker P" first="P" last="Stocker">P. Stocker</name>
</author>
<author><name sortKey="Poggensee, G" sort="Poggensee, G" uniqKey="Poggensee G" first="G" last="Poggensee">G. Poggensee</name>
</author>
<author><name sortKey="Altmann, D" sort="Altmann, D" uniqKey="Altmann D" first="D" last="Altmann">D. Altmann</name>
</author>
<author><name sortKey="Walter, D" sort="Walter, D" uniqKey="Walter D" first="D" last="Walter">D. Walter</name>
</author>
<author><name sortKey="Hellenbrand, W" sort="Hellenbrand, W" uniqKey="Hellenbrand W" first="W" last="Hellenbrand">W. Hellenbrand</name>
</author>
<author><name sortKey="Krause, G" sort="Krause, G" uniqKey="Krause G" first="G" last="Krause">G. Krause</name>
</author>
<author><name sortKey="Eckmanns, T" sort="Eckmanns, T" uniqKey="Eckmanns T" first="T" last="Eckmanns">T. Eckmanns</name>
</author>
</analytic>
<series><title level="j">Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</title>
<idno type="eISSN">1560-7917</idno>
<imprint><date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Disease Outbreaks</term>
<term>Germany (epidemiology)</term>
<term>Humans</term>
<term>Influenza A Virus, H1N1 Subtype (isolation & purification)</term>
<term>Influenza Vaccines</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Interviews as Topic</term>
<term>Middle Aged</term>
<term>Treatment Outcome</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Germany</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Disease Outbreaks</term>
<term>Humans</term>
<term>Interviews as Topic</term>
<term>Middle Aged</term>
<term>Treatment Outcome</term>
<term>Young Adult</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">During the 2009 influenza pandemic, a monovalent AS03-adjuvanted vaccine was almost exclusively used in Germany for immunisation against the 2009 pandemic influenza A(H1N1) virus. One-dose vaccination was recommended for all age groups. We applied the screening method for the rapid assessment of vaccine effectiveness (VE) based on reported data of vaccinated and unvaccinated pandemic influenza cases and vaccination coverage estimates. Preliminary results demonstrate excellent VE in persons aged 14-59 years (96.8%; 95% confidence interval (CI): 95.2-97.9) and moderately high VE in those 60 years or older (83.3%; 95% CI: 71.0-90.5).</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20460094</PMID>
<DateCompleted><Year>2010</Year>
<Month>08</Month>
<Day>18</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>05</Month>
<Day>01</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1560-7917</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>15</Volume>
<Issue>18</Issue>
<PubDate><Year>2010</Year>
<Month>May</Month>
<Day>06</Day>
</PubDate>
</JournalIssue>
<Title>Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</Title>
<ISOAbbreviation>Euro Surveill.</ISOAbbreviation>
</Journal>
<ArticleTitle>Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">19561</ELocationID>
<Abstract><AbstractText>During the 2009 influenza pandemic, a monovalent AS03-adjuvanted vaccine was almost exclusively used in Germany for immunisation against the 2009 pandemic influenza A(H1N1) virus. One-dose vaccination was recommended for all age groups. We applied the screening method for the rapid assessment of vaccine effectiveness (VE) based on reported data of vaccinated and unvaccinated pandemic influenza cases and vaccination coverage estimates. Preliminary results demonstrate excellent VE in persons aged 14-59 years (96.8%; 95% confidence interval (CI): 95.2-97.9) and moderately high VE in those 60 years or older (83.3%; 95% CI: 71.0-90.5).</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wichmann</LastName>
<ForeName>O</ForeName>
<Initials>O</Initials>
<AffiliationInfo><Affiliation>Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany. WichmannO@rki.de</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Stocker</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y"><LastName>Poggensee</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y"><LastName>Altmann</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y"><LastName>Walter</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y"><LastName>Hellenbrand</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y"><LastName>Krause</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y"><LastName>Eckmanns</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2010</Year>
<Month>05</Month>
<Day>06</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Sweden</Country>
<MedlineTA>Euro Surveill</MedlineTA>
<NlmUniqueID>100887452</NlmUniqueID>
<ISSNLinking>1025-496X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053118" MajorTopicYN="Y">Influenza A Virus, H1N1 Subtype</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007252" MajorTopicYN="Y">Influenza Vaccines</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007407" MajorTopicYN="N">Interviews as Topic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year>
<Month>5</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2010</Year>
<Month>5</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2010</Year>
<Month>8</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">20460094</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=ExplorPubmed/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000326 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000326 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    ExplorPubmed
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:20460094
   |texte=   Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:20460094" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a ExplorPubmed

This area was generated with Dilib version V0.6.35.
Data generation: Tue Jun 23 08:20:30 2020. Site generation: Sat Sep 26 09:56:01 2020

	Corpus PubMed
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Corpus PubMed

Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010.

Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010.

Source :

English descriptors

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki